Health Trials

Evaluation of the Effectiveness of Three Tear Substitute Formulations in Postoperative Discomfort After Cataract Surgery

ConditionsCataractDry Eye
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age45-85
SponsorDemocritus University of Thrace

About this trial

The primary objective of this study is the assessment of three tear substitute formulations in terms of postoperative discomfort following cataract extraction surgery by means of phacoemulsification and intraocular lens implantation.

Eligibility criteria

Qualifiers

None

Disqualifiers

Former incisional surgery

Former diagnosis of corneal disease

Autoimmune diseases

Mental diseases

Trial design

Treatments tested in this trial

  • Sodium Hyaluronate 0.15% and Dexpanthenol 2% drops (Hylopan max)
  • Sodium Hyaluronate 0.15% and Trehalose 3% drops (Thealoz duo)
  • Sodium Hyaluronate 0.2% and Amino acids drops (Helenvision ultra)

Treatment groups

300 Participants
are divided into 3 treatment groups

Locations

1
University Hospital of Alexandroupolis68100, AlexandroupoliEvros, Greece

Sponsors and collaborators

Democritus University of Thrace

Lead sponsor

Source ClinicalTrials.gov